Ekso Bionics (EKSO) Short Interest Ratio & Short Volume $0.63 +0.02 (+4.07%) (As of 02:09 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ekso Bionics Short Interest DataEkso Bionics (EKSO) has a short interest of 124,600 shares. This marks a 2.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 119,786 shares to cover all short positions.Current Short Interest124,600 sharesPrevious Short Interest121,500 sharesChange Vs. Previous Month+2.55%Dollar Volume Sold Short$70,610.82Short Interest Ratio1.3 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares21,998,000 sharesPercentage of Shares Shorted0.57%Today's Trading Volume140,726 sharesAverage Trading Volume119,786 sharesToday's Volume Vs. Average117% Short Selling Ekso Bionics? Sign up to receive the latest short interest report for Ekso Bionics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEKSO Short Interest Over TimeEKSO Days to Cover Over TimeEKSO Percentage of Float Shorted Over Time Ad DTIHere’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand. And that’s how you can kickstart your very own “Weekend Side Hustle!” Now that you know that…Let me show you how I target extra income as early as THIS weekend! Ekso Bionics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/2024124,600 shares $70,610.82 +2.6%N/A1.3 $0.57 11/30/2024121,500 shares $84,442.50 +40.0%N/A1.5 $0.70 11/15/202486,800 shares $65,100.00 +17.6%N/A1.1 $0.75 10/31/202473,800 shares $63,172.80 -47.8%N/A0.9 $0.86 10/15/2024141,400 shares $149,884.00 -28.0%N/A1.6 $1.06 9/30/2024196,300 shares $227,708.00 +1.4%N/A2.2 $1.16 Get the Latest News and Ratings for EKSO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ekso Bionics and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024193,600 shares $237,160.00 -46.4%N/A2.2 $1.23 8/31/2024360,900 shares $433,080.00 +393.7%N/A4.3 $1.20 8/15/202473,100 shares $65,095.55 +52.0%N/A0.9 $0.89 7/31/202448,100 shares $50,505.00 -57.2%N/A0.7 $1.05 7/15/2024112,500 shares $154,125.00 -19.4%N/A2.1 $1.37 6/30/2024139,500 shares $147,172.50 +65.9%N/A2.2 $1.06 6/15/202484,100 shares $88,725.50 -28.4%N/A1.2 $1.06 5/31/2024117,500 shares $135,125.00 -27.7%N/A1.5 $1.15 5/15/2024162,600 shares $221,136.00 -26.9%N/A1.2 $1.36 4/30/2024222,300 shares $275,652.00 +16.8%N/A1.6 $1.24 4/15/2024190,300 shares $274,032.00 +41.7%N/A1.1 $1.44 3/31/2024134,300 shares $182,648.00 +20.8%N/A0.7 $1.36 3/15/2024111,200 shares $146,784.00 -23.4%N/A0.5 $1.32 2/29/2024145,100 shares $275,690.00 -15.7%N/A0.7 $1.90 2/15/2024172,100 shares $351,084.00 -32.0%N/A1 $2.04 1/31/2024253,000 shares $579,370.00 -32.2%N/A1.4 $2.29 1/15/2024373,300 shares $623,411.00 +44.8%N/A2.3 $1.67 12/31/2023257,900 shares $644,750.00 -13.9%2.2%2.1 $2.50 12/15/2023299,600 shares $401,464.00 +206.0%2.6%3.5 $1.34 11/30/202397,900 shares $171,325.00 +37.7%0.8%1.3 $1.75 11/15/202371,100 shares $98,829.00 +109.7%0.6%1 $1.39 10/31/202333,900 shares $36,951.00 -2.3%0.3%0.5 $1.09 10/15/202334,700 shares $26,996.60 -13.7%0.3%0.7 $0.78 9/30/202340,200 shares $29,466.60 -45.8%0.4%0.8 $0.73 9/15/202374,200 shares $53,898.88 +105.5%0.7%1.5 $0.73 8/31/202336,100 shares $32,500.83 +32.7%0.3%0.7 $0.90 8/15/202327,200 shares $29,648.00 -14.5%0.2%0.6 $1.09 7/31/202331,800 shares $36,888.00 -10.4%0.3%0.9 $1.16 7/15/202335,500 shares $42,955.00 -28.7%0.3%1.3 $1.21 6/30/202349,800 shares $71,214.00 +45.6%0.4%1.9 $1.43 6/15/202334,200 shares $46,512.00 -2.3%0.3%1.3 $1.36 5/31/202335,000 shares $47,250.00 -4.1%0.3%1.4 $1.35 5/15/202336,500 shares $59,860.00 +9.6%0.3%1.6 $1.64 4/30/202333,300 shares $49,617.00 -19.2%0.3%1.4 $1.49Man Who Called Nvidia Says: “Your Retirement Is Inside This Building.” (Ad)In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. 4/15/202341,200 shares $64,684.00 +5.4%0.4%1.7 $1.57 3/31/202339,100 shares $64,515.00 -20.4%0.3%1.2 $1.65 3/15/202349,100 shares $69,722.00 +1.9%0.4%1.5 $1.42 2/28/202348,200 shares $68,926.00 -3.6%0.4%1.1 $1.43 2/15/202350,000 shares $85,900.00 -0.4%0.4%1 $1.72 1/31/202350,200 shares $84,838.00 -26.8%0.5%1 $1.69 1/15/202368,600 shares $121,422.00 +36.4%0.6%1.3 $1.77 12/30/202250,300 shares $59,857.00 -41.8%0.5%1 $1.19 12/15/202286,400 shares $120,096.00 +100.0%0.8%1.9 $1.39 11/30/202243,200 shares $44,928.00 -11.8%0.4%1.1 $1.04 11/15/202249,000 shares $63,700.00 -20.3%0.4%1.6 $1.30 10/31/202261,500 shares $101,475.00 -18.4%0.5%1.7 $1.65 10/15/202275,400 shares $107,068.00 -11.3%0.7%1.9 $1.42 9/30/202285,000 shares $132,600.00 -10.7%0.7%2.2 $1.56 9/15/202295,200 shares $205,632.00 +2.7%0.8%2 $2.16 8/31/202292,700 shares $217,845.00 +27.0%0.8%0.2 $2.35 8/15/202273,000 shares $181,770.00 -43.6%0.6%0.1 $2.49 7/31/2022129,400 shares $227,744.00 -4.3%1.1%0.2 $1.76 7/15/2022135,200 shares $229,569.60 -7.4%1.2%0.2 $1.70 6/30/2022146,000 shares $240,900.00 -77.7%1.3%0.3 $1.65 6/15/2022655,700 shares $1.23 million +1,322.3%5.6%1.2 $1.88 5/31/202246,100 shares $87,590.00 -20.5%0.4%1.1 $1.90 5/15/202258,000 shares $101,494.20 -11.3%0.5%1.3 $1.75 4/30/202265,400 shares $148,458.00 -15.5%0.6%1.5 $2.27 4/15/202277,400 shares $208,980.00 +14.8%0.7%1.8 $2.70 3/31/202267,400 shares $194,786.00 -3.3%N/A1.4 $2.89 3/15/202269,700 shares $179,826.00 +1.2%0.6%1.1 $2.58 2/28/202268,900 shares $179,140.00 -7.8%0.6%0.9 $2.60 2/15/202274,700 shares $194,220.00 -28.5%0.6%0.9 $2.60 1/31/2022104,400 shares $252,648.00 -11.1%0.8%1.1 $2.42 1/15/2022117,400 shares $297,022.00 +8.1%N/A1 $2.53 12/31/2021108,600 shares $287,790.00 -26.2%0.9%0.9 $2.65 12/15/2021147,100 shares $436,887.00 -11.0%1.2%1.4 $2.97 11/30/2021165,300 shares $537,225.00 -15.1%1.3%1.3 $3.25 11/15/2021194,800 shares $748,032.00 -3.6%1.6%1.6 $3.84 10/29/2021202,000 shares $812,040.00 +42.8%1.6%1.7 $4.02 10/15/2021141,500 shares $582,980.00 +9.7%1.1%1.4 $4.12 9/30/2021129,000 shares $595,980.00 -21.3%1.0%1.3 $4.62 9/15/2021164,000 shares $675,680.00 -8.6%1.3%1.6 $4.12 8/31/2021179,500 shares $858,010.00 -21.9%1.5%2.1 $4.78 8/13/2021229,800 shares $1.10 million -15.8%1.9%2.3 $4.79 7/30/2021272,900 shares $1.33 million +34.9%2.2%1.7 $4.86 7/15/2021202,300 shares $942,718.00 -4.9%1.6%1.1 $4.66 6/30/2021212,800 shares $1.17 million +33.2%1.7%0.9 $5.50 6/15/2021159,800 shares $872,508.00 -40.7%1.3%0.5 $5.46 5/28/2021269,500 shares $1.53 million -30.8%2.2%0.8 $5.68 5/14/2021389,300 shares $1.95 million -0.1%3.2%1.1 $5.02 4/30/2021389,800 shares $2.00 million +36.2%3.2%0.7 $5.12 4/15/2021286,200 shares $1.85 million +67.4%N/A0 $6.48 3/31/2021171,000 shares $1.01 million -5.9%1.5%0.3 $5.90Man Who Called Nvidia Says: “Your Retirement Is Inside This Building.” (Ad)In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company... And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. 3/15/2021181,800 shares $1.33 million -5.7%1.6%0.4 $7.30 2/26/2021192,800 shares $1.38 million -6.3%1.7%0.5 $7.16 2/12/2021205,700 shares $1.98 million -1.5%1.9%0.6 $9.61 1/29/2021208,800 shares $1.94 million -15.5%2.8%0.8 $9.30 1/15/2021247,000 shares $1.99 million +31.4%3.3%1.5 $8.04 12/31/2020188,000 shares $1.17 million +28.9%2.5%1.4 $6.22 12/15/2020145,900 shares $752,844.00 -16.9%2.0%1.4 $5.16 11/30/2020175,500 shares $1.00 million +7.1%2.4%2 $5.72 11/15/2020163,800 shares $753,480.00 -11.0%2.2%1.6 $4.60 10/30/2020184,000 shares $769,120.00 +7.7%2.5%1.8 $4.18 10/15/2020170,800 shares $845,460.00 -12.7%2.3%1.2 $4.95 9/30/2020195,700 shares $929,575.00 -3.9%2.7%0.8 $4.75 9/15/2020203,700 shares $1.08 million -15.2%2.8%0.1 $5.31 8/31/2020240,100 shares $1.19 million -24.8%3.3%0.1 $4.94 8/14/2020319,100 shares $1.87 million -11.0%4.3%0.1 $5.87 7/31/2020358,700 shares $2.34 million -34.3%4.9%0.1 $6.52 7/15/2020546,200 shares $4.28 million -76.6%7.9%0.2 $7.83 6/30/20202,330,000 shares $16.57 million +692.0%36.0%0.8 $7.11 6/15/2020294,200 shares $1.11 million +20.6%4.5%1.3 $3.78 5/29/2020244,000 shares $861,320.00 -4.6%4.7%1.6 $3.53 5/15/2020255,800 shares $767,400.00 -18.9%4.9%2.5 $3.00 4/30/2020315,200 shares $1.23 million +0.4%6.1%3.6 $3.89 4/15/2020314,000 shares $1.06 million -3.7%6.1%3.7 $3.38 3/31/2020326,100 shares $1.29 million -93.4%6.3%3.9 $3.96 3/13/20204,900,300 shares $13.62 million +5.8%8.0%6.2 $2.78 2/28/20204,630,000 shares $972,300.00 +6.2%7.5%4.3 $0.21 2/14/20204,360,000 shares $1.26 million +6.1%N/A4.4 $0.29 1/31/20204,110,000 shares $1.52 million +30.5%N/A4.4 $0.37 1/15/20203,150,000 shares $1.17 million +15.4%N/A4 $0.37 EKSO Short Interest - Frequently Asked Questions What is Ekso Bionics' current short interest? Short interest is the volume of Ekso Bionics shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 124,600 shares of EKSO short. Learn More on Ekso Bionics' current short interest. What is a good short interest ratio for Ekso Bionics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EKSO shares currently have a short interest ratio of 1.0. Learn More on Ekso Bionics's short interest ratio. Is Ekso Bionics' short interest increasing or decreasing? Ekso Bionics saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 124,600 shares, an increase of 2.6% from the previous total of 121,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ekso Bionics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "machinery" compare to Ekso Bionics: Tungray Technologies Inc. (0.08%), SCHMID Group (0.53%), ZOOZ Power Ltd. (1.38%), Fuel Tech, Inc. (0.26%), CVD Equipment Co. (0.54%), LiqTech International, Inc. (1.25%), Art's-Way Manufacturing Co., Inc. (0.34%), Nauticus Robotics, Inc. (8.05%), China Yuchai International Limited (0.03%), Novo Integrated Sciences, Inc. (0.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Ekso Bionics stock? Short selling EKSO is an investing strategy that aims to generate trading profit from Ekso Bionics as its price is falling. EKSO shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ekso Bionics? A short squeeze for Ekso Bionics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EKSO, which in turn drives the price of the stock up even further. How often is Ekso Bionics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EKSO, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies TRSG Short Interest Data SHMD Short Interest Data ZOOZ Short Interest Data FTEK Short Interest Data CVV Short Interest Data LIQT Short Interest Data ARTW Short Interest Data KITT Short Interest Data CYD Short Interest Data NVOS Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EKSO) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredThe Next Big Thing in AI: Musk’s Secret SupplierWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
